Boston Scientific cyberattack disrupts operations
Analysis based on 16 articles · First reported Aug 26, 2026 · Last updated Aug 26, 2026
The cyberattack on Boston Scientific is expected to negatively impact its operations and financial performance in the near term, leading to a decline in its stock price. The broader healthcare sector may face increased scrutiny and investor concern over cybersecurity vulnerabilities, potentially affecting valuations of other medical device makers and healthcare companies.
Boston Scientific disclosed on August 25 that it detected a cybersecurity incident affecting certain information technology systems, disrupting global operations including order processing and shipping. The company activated incident-response procedures and is working with third-party cybersecurity specialists to investigate and contain the threat. The full scope and potential material impact are not yet determined, and disruptions are expected to continue. Shares fell 3.5-5% in premarket trading. This incident is part of a series of cyberattacks targeting the healthcare sector, including recent attacks on Abbott Laboratories, Stryker, Medtronic, Clover Health, Novo Nordisk, and KC Pharmaceuticals.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard